Abstract

BackgroundAlthough exosomes, as byproducts of human umbilical cord mesenchymal stem cells (hUC-MSCs), have been demonstrated to be an effective therapy for traumatic spinal cord injury (SCI), their mechanism of action remains unclear.MethodsWe designed and performed this study to determine whether exosomes attenuate the lesion size of SCI by ameliorating neuronal injury induced by a secondary inflammatory storm and promoting neurite outgrowth. We determined the absolute levels of all exosomal miRNAs and investigated the potential mechanisms of action of miR-199a-3p/145-5p in inducing neurite outgrowth in vivo and in vitro.ResultsmiR-199a-3p/145-5p, which are relatively highly expressed miRNAs in exosomes, promoted PC12 cell differentiation suppressed by lipopolysaccharide (LPS) in vitro through modulation of the NGF/TrkA pathway. We also demonstrated that Cblb was a direct target of miR-199a-3p and that Cbl was a direct target of miR-145-5p. Cblb and Cbl gene knockdown resulted in significantly decreased TrkA ubiquitination levels, subsequently activating the NGF/TrkA downstream pathways Akt and Erk. Conversely, overexpression of Cblb and Cbl was associated with significantly increased TrkA ubiquitination level, subsequently inactivating the NGF/TrkA downstream pathways Akt and Erk. Western blot and coimmunoprecipitation assays confirmed the direct interaction between TrkA and Cblb and TrkA and Cbl. In an in vivo experiment, exosomal miR-199a-3p/145-5p was found to upregulate TrkA expression at the lesion site and also promote locomotor function in SCI rats.ConclusionsIn summary, our study showed that exosomes transferring miR-199a-3p/145-5p into neurons in SCI rats affected TrkA ubiquitination and promoted the NGF/TrkA signaling pathway, indicating that hUC-MSC-derived exosomes may be a promising treatment strategy for SCI.

Highlights

  • Acute traumatic spinal cord injury (SCI) has a prevalence rate of 10–83 per million [1] worldwide each year and usually results in devastating functional loss below the level of the injured spinal cord

  • In summary, our study showed that exosomes transferring miR-199a-3p/145-5p into neurons in SCI rats affected TrkA ubiquitination and promoted the Neuronal growth factor (NGF)/TrkA signaling pathway, indicating that Human umbilical cord mesenchymal stem cell (hUC-MSC)-derived exosomes may be a promising treatment strategy for SCI

  • Exosomal miRNA profile analyzed by absolute quantitative sequencing We obtained hUC-MSCs from Guangzhou Selera Stem Cell Technology Co., Ltd., and the cells that presented a long spindle shape were identified by flow cytometry

Read more

Summary

Introduction

Acute traumatic spinal cord injury (SCI) has a prevalence rate of 10–83 per million [1] worldwide each year and usually results in devastating functional loss below the level of the injured spinal cord. Even though SCI patients achieve certain recovery of locomotion [6, 7], injured axons rarely reconnect to the same extent as axons in the normal spinal cord, and patient motor function never returns to normal [8]. Promoting neurite outgrowth and improving the microenvironment of the remaining neurons should be essential for locomotor recovery in SCI patients. As byproducts of human umbilical cord mesenchymal stem cells (hUC-MSCs), have been demonstrated to be an effective therapy for traumatic spinal cord injury (SCI), their mechanism of action remains unclear

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call